Clinical Trials Logo

Clinical Trial Summary

Low flow anesthesia (LFA) is used less than desirable, partly because one has considered that there might be danger of underdosing of anesthesia gas and thus risk of awareness under anesthesia.LFA has several advantages such as reducing loss of moisture and heat in the inhaled air under anesthesia and to reduce the consumption of anesthetic gas. A few anesthesia machines include an automatic gas control system: the Aisys machine, by GE Healthcare (Madison, WI, USA), and the Flow-i machine, by Maquet (Sweden).

Since these machines were introduced, only a few studies have reported their functionality and effect on gas consumption. 20 to 55% reduction of gas consumption was found. The potential reduction may have been underestimated because in the majority of cases a FGF higher than 1 l/min was still used.

In this study the consumption of anesthetic gas (desflurane) delivered by two different anesthesia machines (Aisys and Flow-i) will be compared, with and without gas control delivery systems. Gas consumption and the time needed to reach the target level of anesthetic gas concentration will be assessed. Data needed will be collected directly from the anesthesia machine, PICIS ( Electronic anesthesia record) and EPJ (Electronic patient journal). The results of this study are of interest for intraoperative ventilation and of economic and ecological interest


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02774031
Study type Interventional
Source St. Olavs Hospital
Contact
Status Completed
Phase N/A
Start date May 2016
Completion date October 20, 2017

See also
  Status Clinical Trial Phase
Completed NCT02244151 - Evaluation of Time Interval Between Ovulation Trigger With Triptorelin Acetate and Oocyte Retrieval Phase 2
Completed NCT04735549 - Vulvovaginal Atrophy Correction Using Neodymium Laser N/A
Recruiting NCT05000957 - Pelvic Organs Prolapse Treatment Using Neodymium Laser N/A
Completed NCT03562897 - Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer Phase 2
Recruiting NCT01765322 - The Effect of Laser-assisted Zona Thinning on the Implantation Rate in the Women of Advanced Age N/A
Not yet recruiting NCT05585476 - A Laser and Topical Treatment Combination in the Vulvo-vaginal Atrophy Management in Breast Cancer Patients. N/A
Withdrawn NCT03996057 - Methenamine in a Non-antibiotic, Multimodal Approach to UTI Prevention Phase 4
Recruiting NCT06237920 - Stage II-IIIa Urothelial Cancer Randomizing Pre-operative Nivolumab With or Without Relatlimab Phase 2
Recruiting NCT06114940 - Neoadjuvant Immune-based Combinations in Patients Undergoing Nephrectomy for Locally Advanced ccRCC Phase 2
Completed NCT05463081 - Clinical Trial of "Magic Gyno" Laser Device N/A
Completed NCT03996603 - Investigation of Microbiomes of Postmenopausal Women Looking for Outcomes and Response to Estrogen Therapy Phase 4